These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33103527)

  • 61. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients.
    Zhang Y; Zhang Y; Yin Y; Li S
    Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer.
    Sun B; Liu HF; Ding Y; Li Z
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3061-3066. PubMed ID: 29863251
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
    Bononi I; Comar M; Puozzo A; Stendardo M; Boschetto P; Orecchia S; Libener R; Guaschino R; Pietrobon S; Ferracin M; Negrini M; Martini F; Bovenzi M; Tognon M
    Oncotarget; 2016 Dec; 7(50):82700-82711. PubMed ID: 27716620
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serum miR-223: A Validated Biomarker for Detection of Early-Stage Non-Small Cell Lung Cancer.
    D'Antona P; Cattoni M; Dominioni L; Poli A; Moretti F; Cinquetti R; Gini E; Daffrè E; Noonan DM; Imperatori A; Rotolo N; Campomenosi P
    Cancer Epidemiol Biomarkers Prev; 2019 Nov; 28(11):1926-1933. PubMed ID: 31488416
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Circulating cell-free DNA as a diagnostic and prognostic biomarker for non-small-cell lung cancer: a systematic review and meta-analysis.
    Chen Z; Miao H; Zeng Q; Xu S; Chen Z; Liu K
    Biomark Med; 2020 May; 14(7):587-597. PubMed ID: 31845833
    [No Abstract]   [Full Text] [Related]  

  • 66. Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression.
    Grimolizzi F; Monaco F; Leoni F; Bracci M; Staffolani S; Bersaglieri C; Gaetani S; Valentino M; Amati M; Rubini C; Saccucci F; Neuzil J; Tomasetti M; Santarelli L
    Sci Rep; 2017 Nov; 7(1):15277. PubMed ID: 29127370
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis.
    Luo J; Shen L; Zheng D
    Sci Rep; 2014 Sep; 4():6269. PubMed ID: 25201768
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Circulating microRNA-339-5p and -21 in plasma as an early detection predictors of lung adenocarcinoma.
    Sun Y; Mei H; Xu C; Tang H; Wei W
    Pathol Res Pract; 2018 Jan; 214(1):119-125. PubMed ID: 29103767
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A combined panel of circulating microRNA as a diagnostic tool for detection of the non-small cell lung cancer.
    Abdollahi A; Rahmati S; Ghaderi B; Sigari N; Nikkhoo B; Sharifi K; Abdi M
    QJM; 2019 Oct; 112(10):779-785. PubMed ID: 31236600
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC.
    Ulivi P; Foschi G; Mengozzi M; Scarpi E; Silvestrini R; Amadori D; Zoli W
    Int J Mol Sci; 2013 May; 14(5):10332-42. PubMed ID: 23681013
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of Circulating miR-762 as a Novel Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer.
    Chen L; Li Y; Lu J
    Technol Cancer Res Treat; 2020; 19():1533033820964222. PubMed ID: 33317398
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in
    Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q
    J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expression of miR-148/152 family as potential biomarkers in non-small-cell lung cancer.
    Li L; Chen YY; Li SQ; Huang C; Qin YZ
    Med Sci Monit; 2015 Apr; 21():1155-61. PubMed ID: 25904302
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serum microRNA biomarkers for detection of non-small cell lung cancer.
    Hennessey PT; Sanford T; Choudhary A; Mydlarz WW; Brown D; Adai AT; Ochs MF; Ahrendt SA; Mambo E; Califano JA
    PLoS One; 2012; 7(2):e32307. PubMed ID: 22389695
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
    Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
    Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical Significance of miR-210 and its Prospective Signaling Pathways in Non-Small Cell Lung Cancer: Evidence from Gene Expression Omnibus and the Cancer Genome Atlas Data Mining with 2763 Samples and Validation via Real-Time Quantitative PCR.
    He RQ; Cen WL; Cen JM; Cen WN; Li JY; Li MW; Gan TQ; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 46(3):925-952. PubMed ID: 29669324
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer.
    Lu S; Kong H; Hou Y; Ge D; Huang W; Ou J; Yang D; Zhang L; Wu G; Song Y; Zhang X; Zhai C; Wang Q; Zhu H; Wu Y; Bai C
    Lung Cancer; 2018 Sep; 123():44-51. PubMed ID: 30089594
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung cancer.
    Chu G; Zhang J; Chen X
    J Drug Target; 2016 Aug; 24(7):613-7. PubMed ID: 26581116
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Predicative values of serum microRNA-22 and microRNA-126 levels for non-small cell lung cancer development and metastasis: a case-control study.
    Shang AQ; Xie YN; Wang J; Sun L; Wei J; Lu WY; Lan JY; Wang WW; Wang L; Wang LL
    Neoplasma; 2017; 64(3):453-459. PubMed ID: 28253725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.